Dr. Scott Chih-Hsi Kuo

Role: Visitor

Email: c.kuo13@imperial.ac.uk



Dr. Scott Chih-Hsi Kuo joined the Discovery Sciences Group in February 2014. He served as a respiratory consultant doctor in Department of Thoracic Medicine of Chang Gung Memorial Hospital, Taipei, Taiwan for 8 years.  His personal research interest focused on lung cancer diagnosis and treatment.  He is currently working on the eTRIKs and UBIOPRED project and focusing on methods of data mining and pathway modelling in a way of clinical interests.



Journal Papers

Chronic Obstructive Pulmonary Disease in Stage I Non-small Cell Lung Cancer That Underwent Anatomic Resection

Scott Chih-Hsi Kuo, Wu CY, Lee KY, Lin SM, Chung FT, Lo YL, Liu CY, Hsiung TC, Yang CT, and Wu YC.
COPD. 2014 (2014)

Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country

Scott Chih-Hsi Kuo, Lo CY, Chung FT, Lee KY, Lin SM, Wang CH, Heh CC, Chen HC, and Kuo HP..
PLoS One. 2012 (2012)

Diagnostic value of EBUS-TBNA for lung cancer with non-enlarged lymph nodes: a study in a tuberculosis-endemic country

Scott Chih-Hsi Kuo, Chen HC, Chung FT, Lo YL, Lee KY, Wang CW, Kuo WH, Yen TC, and Kuo HP.
PLoS One. 2011 (2011)

Subsequent chemotherapy improves survival outcome in advanced NSCLC with acquired tyrosine kinase inhibitor resistance

Scott Chih-Hsi Kuo, Lin SM, Lee KY, Chung FT, M, Hsieh MH, Fang YF, Yu CT, and Kuo HP.
Clinical Lung Cancer. 2010 (2010)